Temperature Excursion in a −20°C Investigational Product Freezer
During a routine monitoring visit at Site 104 for a Phase II double-blind study, you review the investigational product (IP) freezer data logger. The protocol requires storage at −20°C ±5°C. The logger shows a 36-hour excursion over a holiday weekend, with a maximum of −13.8°C; the clinic was closed and the alarm was not configured to notify staff. Seven subjects have been randomized at the site, and three received kits from the affected batch. One of those three was dosed two days after the excursion. The site coordinator says the vials 'looked frozen' and no subjects reported problems. There are no manual temperature logs for the two days before the excursion because the regular coordinator was on leave and the backup did not record temperatures. The sponsor's IP manual says excursions outside 2–8°C for refrigerated product require quarantine, but the manual does not specifically address frozen product. The site has not quarantined the remaining kits. You must decide what to do before leaving the site.
1. What immediate actions should you take regarding the affected IP and the three exposed subjects, and what information do you need before recommending whether dosing can continue?
Read the worked answer
Quarantine all remaining kits from the affected batch and any kits stored in the same freezer; label them 'do not use' and ask the site to move them to a qualified freezer with continuous monitoring. Do not let the site discard them. Retrieve the logger file, calibration certificate, alarm settings, and any manual logs. For the three exposed subjects, contact the investigator the same day to establish kit numbers, administration dates, dose number, and any infusion or injection reactions. The fact that vials 'looked frozen' is not sufficient: protein aggregation or potency loss may not be visible. Request the sponsor's IP quality and stability assessment for a −13.8°C excursion; the 2–8°C rule does not answer the frozen-product question. Before leaving, instruct the site to hold further dosing of affected kits pending sponsor and medical monitor review. If a subject is due for dosing before that review, escalate to the medical monitor for a benefit-risk decision; the CRA should not make that call alone.
2. How would you classify and report this event? Address protocol deviation, IRB and sponsor notification, and whether it meets serious breach criteria.
Read the worked answer
This is a protocol deviation involving IP storage outside the allowed range. It is a potential serious breach if it substantially affects subject safety or data reliability. The 36-hour duration, three exposed subjects, and absent alarm increase concern, but the CRA should present facts to the sponsor and medical monitor rather than making the final legal classification alone. Report to the sponsor within the sponsor's specified timeline, often 24 hours for urgent safety issues, and document the notification in the monitoring report. Notify the IRB according to its policy; many IRBs require prompt reporting of deviations involving risk even when not serious. If stability data show lost potency, an urgent safety measure and possibly subject notification may be needed. Document who was notified, when, and by what method. Also assess whether the failure to configure alarms is a systemic GCP issue, not merely a one-time lapse.
3. What documentation and corrective and preventive action (CAPA) would you require from the site to prevent recurrence?
Read the worked answer
Require a monitoring report entry with logger data, kit numbers, subject IDs, dosing dates, quarantine evidence, and all communications. The site should provide a deviation report and CAPA covering: assigning a qualified backup with defined after-hours responsibility; configuring alarms with notification to at least two staff; adding daily manual temperature checks during closures; training staff on the IP manual and excursion procedures; and performing a documented alarm test. The CAPA should be proportionate to the failure, which involved alarm configuration, backup coverage, and documentation, not just a reminder. Ask for evidence of training records and alarm test results. Track the CAPA to closure and verify implementation at the next visit.